Moolec Science Files Q3 2023 Unaudited Financials
Ticker: MLECW · Form: 6-K · Filed: Jan 22, 2024 · CIK: 1937737
Complexity: simple
Sentiment: neutral
Topics: financial-statements, interim-report, foreign-issuer, quarterly-update
TL;DR
**Moolec just dropped its Q3 2023 financials, time to check their numbers!**
AI Summary
Moolec Science SA, a foreign private issuer, filed a 6-K on January 22, 2024, to provide its unaudited interim condensed consolidated financial statements for the period ending September 30, 2023, and June 30, 2023, as well as for the three-month periods ended September 30, 2023, and 2022. This filing, signed by CEO Gastón Paladini, is crucial for investors as it offers the latest financial health update, allowing them to assess the company's performance and make informed decisions about their investment in Moolec Science SA (ticker 001-41586).
Why It Matters
This filing provides the most recent financial data for Moolec Science SA, enabling investors to evaluate the company's performance and financial stability, which directly impacts stock valuation.
Risk Assessment
Risk Level: medium — The filing itself is routine, but the financial statements it contains could reveal significant risks or opportunities, making the overall situation medium risk until the financials are analyzed.
Analyst Insight
A smart investor would immediately review the unaudited interim condensed consolidated financial statements (Exhibit 99) to assess Moolec Science SA's financial health, revenue, expenses, and profitability for the reported periods before making any investment decisions.
Key Numbers
- 001-41586 — Commission File Number (identifies Moolec Science SA's registration with the SEC)
- 20230930 — Conformed Period of Report (indicates the period covered by the financial statements)
Key Players & Entities
- Moolec Science SA (company) — the registrant filing the 6-K
- Gastón Paladini (person) — Chief Executive Officer who signed the filing
- September 30, 2023 (date) — the end date for the most recent unaudited interim financial statements
- January 22, 2024 (date) — the date the 6-K report was filed
Forward-Looking Statements
- Analysts will now update their financial models for Moolec Science SA based on the newly released unaudited interim condensed consolidated financial statements. (Moolec Science SA) — high confidence, target: Q1 2024
- The stock price of Moolec Science SA may react to the financial performance revealed in the unaudited statements. (Moolec Science SA) — medium confidence, target: January 2024
FAQ
What specific financial documents are included in this 6-K filing?
This 6-K filing includes Moolec Science SA's unaudited interim condensed consolidated financial statements as of September 30, 2023, and June 30, 2023, and for the three-month periods ended September 30, 2023, and 2022, as Exhibit 99.
Who signed this 6-K filing on behalf of Moolec Science SA?
The 6-K filing was signed by Gastón Paladini, the Chief Executive Officer of Moolec Science SA, on January 22, 2024.
What is the primary purpose of Moolec Science SA filing a Form 6-K?
Moolec Science SA, as a foreign private issuer, files a Form 6-K to report material information to the SEC that is made public in its home country or is distributed to its shareholders, in this case, its interim financial statements.
What is Moolec Science SA's business address as listed in the filing?
Moolec Science SA's business address is 17, Boulevard F. W. Raiffeisen, L-2411 Luxembourg, Grand Duchy of Luxembourg.
What is the fiscal year end for Moolec Science SA?
Moolec Science SA's fiscal year end is June 30, as indicated by 'FISCAL YEAR END: 0630' in the filing header.
Filing Stats: 238 words · 1 min read · ~1 pages · Grade level 10 · Accepted 2024-01-22 15:09:43
Filing Documents
- ea191869-6k_moolec.htm (6-K) — 14KB
- ea191869ex99_moolec.htm (EX-99) — 453KB
- 0001213900-24-005272.txt ( ) — 4231KB
- cik0001937737-20230930.xsd (EX-101.SCH) — 93KB
- cik0001937737-20230930_cal.xml (EX-101.CAL) — 47KB
- cik0001937737-20230930_def.xml (EX-101.DEF) — 257KB
- cik0001937737-20230930_lab.xml (EX-101.LAB) — 496KB
- cik0001937737-20230930_pre.xml (EX-101.PRE) — 266KB
- ea191869-6k_moolec_htm.xml (XML) — 516KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rules 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of January 2024 Commission File Number: 001-41586 MOOLEC SCIENCE SA (Exact name of Registrant as Specified in Its Charter) 17, Boulevard F. W. Raiffeisen L-2411 Luxembourg, Grand Duchy of Luxembourg (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBIT LIST Exhibit No. Description 99 Moolec Science SA unaudited interim condensed consolidated financial statements as of September 30, 2023 and June 30, 2023, and for the three month period ended September 30, 2023 and 2022. 101.INS Inline XBRL Instance Document. 101.SCH Inline XBRL Taxonomy Extension Schema Document. 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document. 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document. 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document. 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document. 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MOOLEC SCIENCE SA (Registrant) Dated: January 22, 2024 By: /s/ Gastn Paladini Name: Gastn Paladini Title: Chief Executive Officer 2